Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease

Details for Australian Patent Application No. 2010324997 (hide)

Owner Gilead Sciences, Inc.

Inventors Bhatt, Elizabeth Peters; Macleod, David Lloyd; McKevitt, Matthew Thomas; Newcomb, Terry Glenn

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2010324997

PCT Pub. Number WO2011/066107

Priority 61/264,160 24.11.09 US

Filing date 10 November 2010

Wipo publication date 3 June 2011

International Classifications

A61K 31/665 (2006.01) - having oxygen as a ring hetero atom, e.g. fosfomycin

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/7036 (2006.01)

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

31 May 2012 PCT application entered the National Phase

  PCT publication WO2011/066107 Priority application(s): WO2011/066107

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010325011-Reducing photovoltaic array voltage during inverter re-enablement

2010324993-Method and system for thin chip digester cooking